SEDA PHARMA DEVELOPMENT SERVICES LTD.

Capital raised per employee divides the equity SEDA PHARMA DEVELOPMENT SERVICES LTD. raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.

A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. SEDA PHARMA DEVELOPMENT SERVICES LTD. has 4 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.